Contact Lens Wettability
The Impact of Short Term Wearing Time on In Vivo and Ex Vivo Wettability
1 other identifier
interventional
55
1 country
1
Brief Summary
The purpose of this study is to compare the wettability of contact lenses disinfected with three marketed contact lens care solutions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 4, 2006
CompletedFirst Posted
Study publicly available on registry
July 6, 2006
CompletedJuly 19, 2006
July 1, 2006
July 4, 2006
July 17, 2006
Conditions
Outcome Measures
Primary Outcomes (2)
To investigate the impact of wearing time and contact lens care solutions on in
vivo and ex vivo wettability of currently marketed contact lenses
Secondary Outcomes (3)
To determine if there is a correlation between in vivo wettability, ex vivo
wettability and in-eye comfort. To determine if comfort and wettability vary
between symptomatic and asymptomatic lens wearers.
Interventions
Eligibility Criteria
You may qualify if:
- Has had an oculo-visual examination in the last two years.
- Is at least 18 years old and has full legal capacity to volunteer or is at least 16 years old, has a parent or guardian's permission to participate in the study and has read the Information and Consent Letter for adolescents.
- \. Has read and understood the Information Consent Letter (Appendix II). 5. Is willing and able to follow participant instructions for product usage and meet the protocol-specified schedule of follow-up visits.
- \. Has a refractive error that is correctable with the prescription of the available study lenses.
- \. Has a refractive error that is correctable to at least 20/25 distance visual acuity with contact lenses in each eye.
- \. Has acceptable fit with the study lenses. 9. Has clear corneas, and ocular clinical findings are considered "normal".
You may not qualify if:
- Has any systemic disease that may affect ocular health.
- Is using any systemic or topical medications that may affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that may affect the wearing of contact lenses.
- Has any clinically significant lid or conjunctival abnormalities, meibomian gland dysfunction, neovascularization, corneal scars or corneal opacities.
- Has limbal injection, bulbar injection or corneal staining that, in the investigator's opinion, is clinically significant.
- Has pinguecula and/or pterygium that, in the investigator's judgement, makes contact lens wear inadvisable.
- Has refractive astigmatism of more than 0.75 D.
- Has corneal distortion resulting from rigid lens wear.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of clinical or research study.
- Is pregnant or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Waterloolead
- Alcon Researchcollaborator
Study Sites (1)
Centre for Contact Lens Research, University of Waterloo
Waterloo, Ontario, N2L 3G1, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Craig Woods, PhD
University of Waterloo
- PRINCIPAL INVESTIGATOR
Desmond Fonn, MOptom
University of Waterloo
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 4, 2006
First Posted
July 6, 2006
Study Start
July 1, 2005
Last Updated
July 19, 2006
Record last verified: 2006-07